The Patent Finder
CB

Capella Bioscience Ltd.

First filing 2019
OverviewNotableFeesChangesFamiliesPatent listSources & methods

One patent currently held, every record listed here

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
24 more records may belong here and await a decision; they are not counted.

The next term ends in Oct 2039. from the record

Of the 3 now held by other companies, 3 name Centessa Pharmaceuticals UK Limited as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2039
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2023 to 2043.
US 11,827,673 Antigen Binding Molecules That Bind Light Feb 13, 2039
US 12,227,580 Antigen Binding Molecules That Bind LIGHT Oct 27, 2039
US 12,686,717 ANTI-PD-L1 Antibodies Aug 12, 2043
US 12,760,109 Anti BDCA-2 Antibodies Dec 14, 2043
20272031203520392043
Every computed term in this portfolio is shown above.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable Ends Feb 2039 · High confidence
Also notable
Granted 2026. Too new for citation comparison; protection runs to 2043.
Ends Dec 2043 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

  • 1 of the patents on this record was granted since Aug 16, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 1 of 1

PatentTitleStatusExpiresConfidence
US 12,227,580Antigen Binding Molecules That Bind LIGHT
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 1: 3 patents in force now held by others · 1 patent ended. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited